Conditions: Healthy Volunteers
Allocation: RANDOMIZED | Intervention model: CROSSOVER
Enrollment: 60
Healthy volunteers: yes

Brief summary:
The purpose of this study is to measure and compare the amounts of the study drug evacetrapib found in the blood after taking two different formulations. The study has 3 periods. Participants will take each formulation by mouth at least once. A minimum of 14 days will pass between study drug doses. The safety and tolerability of the study drug will also be examined. Information about any side effects that may occur will also be collected. This study will last approximately 6 weeks.

Detailed description:

Arms:
arm 1: Single oral dose of 130 milligram (mg) evacetrapib tablet on Day 1 of up to 2 of 3 periods arm 2: Single oral dose of 130 mg evacetrapib tablet on Day 1 of up to 2 of 3 periods

Interventions: intervention 1: Evacetrapib
Intervention descriptions: intervention 1: Administered orally

Protocol document: